NCT06096519 Effectiveness and Implementation of Text Messaging to Improve HIV Testing in Adolescents
| NCT ID | NCT06096519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2024-06-13 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2024-06-13 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test the effectiveness of a text message-based intervention on human immunodeficiency virus (HIV) testing behaviors among adolescent (13-19 year old). To test the effectiveness on HIV testing behaviors we will randomize participants to the treatment or an attention matched information only control arm and asses our primary effectiveness outcome of objective HIV testing (e.g., photo of test results).
Eligibility Criteria
Inclusion Criteria: * Have penetrative or oral sex in their lifetime * 13-19 years old * reads in English at a 8th grade level * HIV negative or unknown status * own a cell phone with an unlimited MMS plan and plan to have the same number during the study * can provide informed assent, as shown on a capacity to consent assessment * live in the U.S. or territories. Exclusion Criteria: * Previous lifetime testing for HIV or an STI OR no testing since last sexual experience * HIV positive * Currently on PrEP
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06096519 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 19 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06096519 currently recruiting?
Yes, NCT06096519 is actively recruiting participants. Contact the research team at kathryn.macapagal@northwestern.edu for enrollment information.
Where is the NCT06096519 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06096519 clinical trial?
NCT06096519 is sponsored by Northwestern University. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.